Latest news with #Accurate
Yahoo
3 days ago
- Business
- Yahoo
Accurate Network Services Acquires Shift Support, Expanding IT Capabilities and Client Reach
EDMONTON, AB, June 10, 2025 /CNW/ - Accurate Network Services, a leading provider of IT support and cybersecurity solutions, is pleased to announce the acquisition of Shift Support, an Edmonton-based IT services company known for its strong client relationships and personalized service. The acquisition, finalized this month, brings together two values-aligned organizations dedicated to doing IT differently. Together, they will focus on proactive support, long-term partnerships, and measurable business impact for clients. Luke Williamson, Founder and President of Accurate Network Services, shared his enthusiasm about the milestone: "Bringing Shift Support into the Accurate family is about more than growth—it's about deepening our promise to clients. Shift's culture of proactive service and their reputation for solving problems before they happen mirror the values we built Accurate on 18 years ago. Together, we're combining Shift's nimble, client-first approach with Accurate's scale, security expertise, and 24/7 support. The result is a stronger partner who can move faster, protect clients better, and keep their businesses running without interruption. We're excited for this next chapter and grateful to the Shift team and clients for trusting us to help them succeed." Founded nearly two decades ago, Accurate has grown from a solo venture into a 60-person team serving clients across Western Canada. The addition of Shift Support will expand Accurate's presence not only in Edmonton and Alberta but Canada-wide and bring in a talented team of professionals who share the same customer-first mindset. Mike Alexander, Co-Founder of Shift Support, added: "The acquisition of Shift represents an exciting step forward - one built on a shared commitment to client success, a strong service philosophy, and a belief in doing IT differently. By joining forces with Accurate Networks, we're creating new growth opportunities for our team and expanding our ability to serve clients with even greater depth, scale, and expertise. Shift and Accurate Networks are aligned around values that matter: personalized support, long-term relationships, and a proactive approach to IT. Our clients can expect continuity where it counts, and improvements where it makes a difference. We're incredibly excited about this next chapter - one that brings greater resources, more capabilities, and a renewed commitment to delivering exceptional service, every step of the way." As part of the transition, clients can expect continuity in the people and services they've come to trust, along with new benefits such as: Enhanced phone and after-hours support Additional project resources for faster turnaround Access to Accurate's mature cybersecurity department A commitment to regular client feedback and personalized service evolution Accurate Network Services is already reaching out to Shift Support clients to learn what matters most to them during this integration and ensure a seamless experience throughout the process. About Accurate Network ServicesAccurate is a Canadian IT services provider offering managed IT, cybersecurity, and project services to organizations of all sizes. Founded in 2006, Accurate is driven by a mission to better the lives of those they work with—clients, team members, and communities alike. SOURCE Accurate Networks View original content to download multimedia:
Cision Canada
3 days ago
- Business
- Cision Canada
Accurate Network Services Acquires Shift Support, Expanding IT Capabilities and Client Reach
EDMONTON, AB, June 10, 2025 /CNW/ - Accurate Network Services, a leading provider of IT support and cybersecurity solutions, is pleased to announce the acquisition of Shift Support, an Edmonton-based IT services company known for its strong client relationships and personalized service. The acquisition, finalized this month, brings together two values-aligned organizations dedicated to doing IT differently. Together, they will focus on proactive support, long-term partnerships, and measurable business impact for clients. , Founder and President of Accurate Network Services, shared his enthusiasm about the milestone: "Bringing Shift Support into the Accurate family is about more than growth—it's about deepening our promise to clients. Shift's culture of proactive service and their reputation for solving problems before they happen mirror the values we built Accurate on 18 years ago. Together, we're combining Shift's nimble, client-first approach with Accurate's scale, security expertise, and 24/7 support. The result is a stronger partner who can move faster, protect clients better, and keep their businesses running without interruption. We're excited for this next chapter and grateful to the Shift team and clients for trusting us to help them succeed." Founded nearly two decades ago, Accurate has grown from a solo venture into a 60-person team serving clients across Western Canada. The addition of Shift Support will expand Accurate's presence not only in Edmonton and Alberta but Canada-wide and bring in a talented team of professionals who share the same customer-first mindset. Mike Alexander, Co-Founder of Shift Support, added: "The acquisition of Shift represents an exciting step forward - one built on a shared commitment to client success, a strong service philosophy, and a belief in doing IT differently. By joining forces with Accurate Networks, we're creating new growth opportunities for our team and expanding our ability to serve clients with even greater depth, scale, and expertise. Shift and Accurate Networks are aligned around values that matter: personalized support, long-term relationships, and a proactive approach to IT. Our clients can expect continuity where it counts, and improvements where it makes a difference. We're incredibly excited about this next chapter - one that brings greater resources, more capabilities, and a renewed commitment to delivering exceptional service, every step of the way." As part of the transition, clients can expect continuity in the people and services they've come to trust, along with new benefits such as: Enhanced phone and after-hours support Additional project resources for faster turnaround Access to Accurate's mature cybersecurity department A commitment to regular client feedback and personalized service evolution Accurate Network Services is already reaching out to Shift Support clients to learn what matters most to them during this integration and ensure a seamless experience throughout the process. About Accurate Network Services Accurate is a Canadian IT services provider offering managed IT, cybersecurity, and project services to organizations of all sizes. Founded in 2006, Accurate is driven by a mission to better the lives of those they work with—clients, team members, and communities alike.
Yahoo
06-02-2025
- Business
- Yahoo
GUERBET : 2024 revenue.
2024 revenue Solid growth momentum for the second year in a row Full-year revenue: €841.1 million, with growth of 9.0% on a like-for-like basis and at CER This performance was achieved thanks to strong momentum in the Americas (+20.5%) and Asia (+10.1%) and despite the contraction of activity in France Details on the 2024 financial statements Expected Restated EBITDA margin close to 14.9% Free cash flow expected to be slightly negative Significant improvement in financial leverage (net debt/EBITDA) Villepinte, February 6, 2025, 5:45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging, is publishing its full-year revenue. At 31 December 2024, the Group's sales totalled €841.1 million, up 7.1% compared with 2023. This change includes an unfavourable currency effect of €12.3 million, mainly due to South American and Asian currencies. At constant exchange rates (CER1), business grew by 8.6% in 2024. At constant exchange rates and on a like-for-like basis, i.e. excluding the urology and Accurate businesses which were sold in July 2024 and January 2025 respectively, growth reached 9.0%. This performance is very close to the annual guidance communicated during the half-year results. It follows another year of remarkable growth of 6.4% at CER in 2023. Breakdown of consolidated Group revenue (IFRS) by quarter In € millions 2023 20242024at CER1Q1 180.6 194.3 +7.6% 196.5Q2 198.0 224.9 +13.6% 226.8Q3 195.2 201.3 +3.1% 205.8Q4 211.8 220.6 +4.1% 224.3Total 785.7 853.4 Constant exchange rates: the exchange rate impact was eliminated by recalculating sales for the period on the basis of the exchange rates used for the previous financial year. Geographical breakdown of consolidated Group revenue (IFRS) In millions of euros,at 31 December 2024 2023 2024 % change 2024at CER1 % changeat CER Sales in EMEA 347.7 352.4 +1.4% 351.6 +1.1% Sales in the Americas 217.6 255.5 +17.4% 262.1 +20.5% Sales in Asia 213.9 229.0 +7.0% 235.4 +10.1% Total like-for-like 779.2 836.9 +7.4%+9.0% Divested businesses (Accurate and urology) 6.5 4.2 - 4.2 - Total 785.7 841.1 +7.1% 853.4 +8.6% Constant exchange rates: the exchange rate impact was eliminated by recalculating sales for the period on the basis of the exchange rates used for the previous financial year. In EMEA, the Group made full-year revenue of €352.4 million, up 1.1% at constant exchange rates and on a like-for-like basis. 2024 saw a contraction in activity in France (-11.8%) following the implementation on 1 March 2024 of a new supply management system between distributors and practitioners. For the record, this contraction was nevertheless accompanied by an improvement in the product mix, which limited the impact on the Group's profitability. Excluding France, growth in the EMEA region was 8.8% at CER. In the Americas, sales increased by 20.5% at CER and on a like-for-like basis in 2024, driven by higher prices and volumes as well as a remarkable performance in Latin America thanks to significant market share gains. In the Americas as a whole, after exceptional momentum linked to the catch-up at the Raleigh site over three consecutive quarters until mid-2024, Guerbet continued to post double-digit growth (+11.8% in the fourth quarter alone). In Asia, the Group saw another very strong year, with annual growth of 10.1% at CER and on a like-for-like basis, driven in particular by China (+10.4%). This performance was achieved despite the decline in activity in South Korea, in connection with a major strike by doctors. In the fourth quarter of 2024, Guerbet generated growth in Asia of +9.3%. Breakdown of consolidated Group revenue (IFRS) by activity In millions of euros,at 31 December 2024 2023 2024 % change 2024at CER1 % changeat CER Diagnostic Imaging 686.3 737.1 +7.4% 748.1 +9.0% MRI 256.9 262.6 +2.2% 264.5 +3.0% X-ray 429.4 474.5 +10.5% 483.6 +12.6% Interventional Imaging 92.9 99.9 +7.5% 101.1 +8.8% Total like-for-like 779.2 836.9 +7.4% 849.2 +9.0% Divested businesses (Accurate and urology) 6.5 4.2 - 4.2 - Total 785.7 841.1 +7.1% 853.4 +8.6% Constant exchange rates: the exchange rate impact was eliminated by recalculating sales for the period on the basis of the exchange rates used for the previous financial year. By activity, sales at CER and on a like-for-like basis in Diagnostic Imaging amounted to €748.1 million at 31 December 2024, up 9.0% (+7.5% in the fourth quarter). In the IRM division, revenue grew by 3.0% year-on-year at CER and on a like-for-like basis. Growth in this division was hampered by the situation in France, which penalised sales of Dotarem® in particular. At the same time, there was a continued ramp-up of EluciremTM sales despite the delay in some markets, particularly in Switzerland where the commercial launch had to be postponed due to a regulatory delay. Excluding the France effect, growth in the IRM division was 9.4%. The X-ray division posted full-year growth of 12.6% at CER and on a like-for-like basis, driven by a sustained increase in volumes and prices for both Xenetix® and Optiray®. Over the year, Guerbet's performance in this activity was driven by both gains in market share and a favourable change in the product mix. In Interventional Imaging, the Group reached a new sales milestone of €100 million in 2024, with revenue at CER and on a like-for-like basis of €101.1 million. This represented growth of 8.8% over the year (+0.3% in the fourth quarter alone) thanks to the increase in prices and volumes for Lipiodol®, which saw particularly strong growth in vascular embolization. 2024 financial statements: confirmation of expected increase in profitability target Slightly negative expected free cash flow and significant improvement in financial leverage The solid growth generated by Guerbet in 2024, despite unprecedented disruptions in the French market, was accompanied by an overall improvement in its product mix and good cost control. The Group therefore is quietly confident it will achieve its profitability target for the 2024 financial year and has even raised this target: the restated EBITDA margin is expected to be close to 14.9%. At the same time, Guerbet now expects a slightly negative free cash flow level in 2024, due to late payments in France in connection with the new distribution channel. However, a significant improvement in the net debt/EBITDA ratio is expected for the 2024 financial year. The Group will take the opportunity during the publication of its full-year results, scheduled for 26 March, to specify its financial objectives for the current financial year. Next event: Publication of 2024 annual results26 March 2025 after market close About GuerbetAt Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. A pioneer in contrast media for 97 years, with more than 2,920 employees worldwide, we continuously innovate and devote 10% of our sales to research and development in four centres in France, the United States and Israel. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €786 million in revenue in 2023. Forward-looking statementsCertain information contained in this press release does not reflect historical data but constitutes forward-looking statements. These forward-looking statements are based on estimates, forecasts, and assumptions, including but not limited to assumptions about the current and future strategy of the Group and the economic environment in which the Group operates. They involve known and unknown risks, uncertainties, and other factors that may result in a significant difference between the Group's actual performance and results and those presented explicitly or implicitly by these forward-looking forward-looking statements are valid only as of the date of this press release, and the Group expressly disclaims any obligation or commitment to publish an update or revision of the forward-looking statements contained in this press release to reflect changes in their underlying assumptions, events, conditions, or circumstances. The forward-looking statements contained in this press release are for illustrative purposes only. Forward-looking statements and information are not guarantees of future performance and are subject to risks and uncertainties that are difficult to predict and are generally beyond the Group's control. These risks and uncertainties include but are not limited to the uncertainties inherent in research and development, future clinical data and analyses (including after a marketing authorization is granted), decisions by regulatory authorities (such as the US Food and Drug Administration or the European Medicines Agency) regarding whether and when to approve any application for a drug, process, or biological product filed for any such product candidates, and their decisions regarding labeling and other factors that may affect the availability or commercial potential of such product candidates. A detailed description of the risks and uncertainties related to the Group's activities can be found in Chapter 4.9 'Risk factors' of the Group's Universal Registration Document filed with the AMF (French financial markets authority) under number D.24-0224 on April 3, 2024, available on the Group's website ( Guerbet Jérôme Estampes, Chief Financial Officer +33 1 45 91 50 00 / Allard, Head of Communications +33 6 30 11 57 82 / Seitosei Actifin Marianne Py, Financial Communications +33 1 80 48 25 31 / Jennifer Jullia, Press +33.1.56.88.11.19 / Attachment 25 0206 CP GBT CA annuel V Final En
